INTRODUCTION
Connective tissue of lung is fundamental to the structural integrity and function of the organ (1, 2) . Knowledge of the chemical nature and the properties of the connective tissue matrix elements in normal lungs, and their alterations in diseased organs is therefore essential to our understanding of the mechanisms involved in pathologic processes. Lung connective tissue is composed of collagen, elastin, and ground substances (3) (4) (5) . Of these, collagen is the most abundant protein, comprising 11% of adult lung (6) ; it has the greatest tensile strength and probably plays an important role in the mechanical properties of lung (7, 8) .
Recent studies from several laboratories have elucidated at least four genetically distinct collagens from various tissues (9) . The most completely characterized and widely distributed in tissues is type I collagen. It is present in nearly all connective tissues, including skin, bone, tendon, aorta, and most parenchymal organs, and it is composed of two al (I) chains and one a2 chain, or [al(I)]2 a2 (10, 11) . Type II collagen, consisting of [al (II)]3, is present solely in cartilage. Type III collagen, with the chain composition of [al(III)]s has recently been isolated from human skin, aorta, and leiomyoma (12) (13) (14) . In addition, basement membranes
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The discovery of the existence of several genetically different collagens in the same tissue has made the questions concerning collagen polymorphism of both the normal and the diseased organs more cogent. In chronic pulmonary fibrosis, histologic evidence suggests that there is an increase in collagen in affected regions of the lung (17) , but to our knowledge there has been no biochemical characterization of the protein in this fibrotic state. Recent work by Bradley et al. (6, 18, 19) has indicated that explants from peripheral portions of normal lung synthesize type I collagen and explants of trachea and the bronchial tree synthesize type II collagen in tissue culture. In addition, type I collagen has been isolated and characterized from normal rabbit lungs (6) . In this study, we report the isolation and characterization of type III and type I collagen from normal adult human lung and their behavior in chronic pulmonary fibrosis. Our results clearly indicate that in fibrotic lung the relative content of type III is markedly diminished, while the content of type I is increased. The degree of lysine hydroxylation seems to be also reduced in the al chains of type I and type III collagen in the diseased lung.
METHODS
Lung samples. Human lung was obtained from adults at the time of autopsy. Diseased lungs were taken from five males (ages 50-70) with idiopathic pulmonary fibrosis. The diagnosis was confirmed by histologic examination of autopsy samples. The normal lungs were obtained from male patients of similar ages as the diseased subjects, who had died of unrelated causes. Only the lungs without gross and microscopic evidence of acute or chronic disease processes were used in this study. All pathologic examinations were carried out by Dr. J. M. Young, Chief, Pathology Service, Memphis Veterans Administration Hospital. The tracheobronchial tissues were removed as much as possible by dissection. The remaining peripheral lung was cut into pieces, ground in a mechanical meat grinder, and homogenized briefly with a Waring blender at 40C (Waring Products Div., Dynamics Corp. of America, New Hartford, Conn.). The homogenate was then washed with large volumes of cold 0.05 M Tris, pH 7.4, to remove relatively large amounts of noncollagenous substances, and finally with cold distilled water. The insoluble tissue residue, which contained over 99% of the original collagen as determined by hydroxyproline analysis (20) , was collected by centrifugation and either used directly for pepsin digestion or CNBr clevage.
Solubilation of collagen by limited pepsin digestion and
isolation of molecular species. The washed lung homogenate residue was suspended in cold 0.5 M acetic acid, and the pH of the suspension adjusted to 2.5 by the addition of formic acid. All operations were performed at 40C. Pepsin was then added (1 g/50 g wet weight) and digestion was allowed to proceed for 72 h with gentle shaking. The undigested residue was separated by centrifugation for 1 h at 10,000 g, and digested two more times with pepsin under identical conditions. Collagen present in the three pepsin extracts was precipitated by dialysis against 0.01 M Na-HPO4 and harvested by centrifugation. The precipitate was redissolved in 0.5 M acetic acid and precipitated again by the addition of NaCl to a final concentration of 1 M. The final precipitate was resolubilized in 0.05 M Tris/1 M NaCI, pH 7.4. Type III collagen was then precipitated by a careful addition of NaCl to a concentration of 1.5 M and collected by centrifugation (12, 14) . Remaining collagen in the supernatant solution (predominently type I) was precipitated by increasing the NaCl concentration to 2.5 M. Each type of collagen was then dissolved in 0.1 M acetic acid, dialyzed exhaustively against the same solution, and lyophilized.
Cleavage with cyanogen bromide. Samples of washed lung homogenates (500-1,000 mg) were suspended in 50-100 ml of 70% formic acid. Samples of purified collagen chains (50-200 mg) were dissolved in 20-50 ml of 70%o formic acid. The suspension or solution was flushed with nitrogen, and a weight of CNBr (Pierce Chemical Co., Rockford, Ill.) equal to two times the weight of the sample was added. Digestion was allowed to proceed for 4 h at 40'C with gentle stirring. Insoluble material, if any, was separated by centrifugation for 10 min at 40,000 g, and the supernate containing the liberated peptides was lyophilized after a 10-fold dilution with cold distilled water. The extent of solubilization of collagenous protein by CNBr digestion was determined by hydroxyproline analysis of portions of the supernate and the residue.
Ion exchange chromatography. Separation of the constituent a-chains of pepsin-solubilized collagen was achieved by chromatography of a heat denatured collagen solution on a column (2.5 X 10 cm) of carboxymethylcellulose (CMcellulose) l (CM-52, Whatman, Inc., Clifton, N. J.) at 430C (21) . Samples were solubilized in 0.02 M sodium acetate/l M urea, pH 4.8, denatured by warming the solution at 430C for 20 min, and applied to the column. The collagen chains were eluted with a linear gradient of NaCl from 0 to 0.1 M over a a total volume of 1,200 ml. The effluent was monitored continuously at 230 nm in a Gilford recording spectrophotometer (model 2400S, Gilford Instrument Laboratories, Inc., Oberlin, Ohio) equipped with a flow cell, and collected in fractions of 10 ml. The fractions corresponding to each peak were pooled, desalted on a column (4 X 60 cm) of Sephadex G-25 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) using 0.1 M acetic acid as the eluent, and lyophilized. Peptides generated by CNBr digestion were chromatographed on a column (0.9 X 15 cm) of CM-cellulose at 430C (22) . Samples (50-100 mg) were dissolved in 5 ml of starting buffer (0.02 N sodium citrate/0.02 M NaCl, pH 3.8 ) and applied to the column equilibrated with the same buffer. Peptides were eluted with a linear gradient formed between 250 ml each of the starting buffer and limiting buffer (0.02 N sodium citrate/0.16 M NaCl, pH 3.8). A flow rate of 48 ml/h was used and the effluent was continuously monitored at 230 nm. The fractions representing each peptide peak were pooled, lyophilized, desalted on Bio-Gel P-2 (Bio-Rad Laboratories, Richmond, Calif.) (100-200 mesh) using 0.1 M acetic acid, and relyophilized.
Certain of the CNBr peptide fractions obtained from the initial CM-cellulose chromatography at pH 3.8 required further fractionation at pH 4.8. A column (0.9 X 10 cm) 'Abbreviation used in this paper: CM-cellulose, carboxymethylcellulose.
CoUagen Polymorphism in Idiopathic Chronic Pulmonary Fibrosis of CM-cellulose was equilibrated with starting buffer (0.02 M sodium acetate, pH 4.8) at 430C, and after application of samples was eluted with a concave gradient prepared from 250 ml of the starting buffer and 415 ml of limiting buffer (0.02 M sodium acetate/0.16 M NaCl, pH 4.8) in a twochamber constant level device (23, 24) .
Other peptide fractions were rechromatographed on a column (0.9 X 7 cm) of phosphocellulose (Whatman Inc., P-11). Samples were dissolved in 2 ml of starting buffer (0.001 M sodium acetate, pH 3.8) and applied to the column equilibrated with the same buffer at 430C. Peptides were then eluted with a linear gradient of NaCl from 0 to 0.1 M over a total volume of 600 ml.
Molecular sieve chromatography. Separation and molecular weight determination of denatured collagen chains and CNBr peptides were achieved on calibrated columns (2 X 120 cm) of agarose beads, A 15m or A 1.5m (200-400 mesh, Bio-Rad Laboratories), or Sephadex G-50 SF (Pharmacia Fine Chemicals, Inc.) in 0.05 M Tris/1 M CaCl2, pH 7.4, at room temperature as described previously (25) . All samples were heated to 430C to ensure denaturation before application to the column. A drop of tritiated water was added to each sample to mark the column volumes (25) .
Amino acid and carbohydrate analyses. For amino acid analysis, samples were hydrolyzed in doubly distilled constant boiling HCl under an atmosphere of nitrogen for 24 h at 110'C. Analyses were performed on an automatic analyzer (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif., model 121) using a four-buffer elution system previously described (26) .
Samples for analysis of hydroxylysine glycosides were hydrolyzed in 2 N NaOH in borosilicate-free test tubes at 1100C for 24 h. Analyses were performed on a Beckman 121 analyzer employing the methods described by Askenasi and Kefalides (27) .
RESULTS
Attempts to extract native collagen directly from normal or fibrotic lungs using 1 M NaCl or 0.5 M acetic acid were unsuccessful due to extremely low yields. Much greater quantities of collagen, however, could be ex-tracted by limited digestion with pepsin. The results are presented in Table I . Generally, the first pepsin extract contained lower yields of solubilized collagen than the second and third extracts. The yields of collagen from pepsin-digested fibrotic lung were higher than for normal lungs (Table I) .
After purification of the pepsin-extracted collagen by dialysis against 0.01 M Na2HPO4, and NaCl precipitation from acetic acid solution, the collagen fraction precipitating at 1.5 M NaCl at pH 7.4 was chromatographed on CM-cellulose. The elution pattern obtained from fibrotic lungs is shown in Fig. 1 . The peaks were identified by their behavior during agarose chromatography (not shown) and amino acid analysis (Table II) . The peak labeled al (III) ( Fig. 1 ), eluted from agarose A 15m as a homogenous peak at the position corresponding to the a-component (mol wt 280,000). Thus, the predominant species of collagen in the 1.5 M NaCl precipitate was type III.
The pepsin-extracted collagen fraction precipitating at the NaCl concentration between 1.5 and 2.5 M at pH 7.4 was also fractionated on CM-cellulose. A representative chromatogram is illustrated again in Fig. 1 . The peak labeled al (I) was identified by its elution position on agarose A 15m chromatography (figure not shown, mol wt 95,000), amino acid analysis (Table II) , and chromatography of a CNBr digest (see below). Significant amounts of the type III chains were also present in the 2.5 M NaCl precipitate, reflecting incomplete precipitation of type III collagen at 1.5 M NaCi (14) . However, gel filtration on agarose A 15m allowed clear-cut separation and purification of [al (III)]s (mol wt 280,000) and a2 (mol wt 95,000). Amino acid analysis (Table II ) and chromatography of CNBr digests of these materials (see below) confirmed their ELUTION VOLUME (ml) 750 FIGURE 1 CM-cellulose chromatography of pepsin-solubilized human lung collagen. The lower curve represents the elution pattern obtained from the fraction precipitating at 1.5 M NaCl at pH 7.4 (indicated by an arrow), and the upper curve, the fraction precipitating between 1.5-2.5 M NaCl (indicated by an arrow). The peaks were identified by their behavior during agarose A 15m chromatography and subsequent analyses of their amino acid compositions and the CNBr peptides. The presence of the al(III) chains in the 1.5-2.5 NaCl precipitate (upper curve) is due to incomplete precipitation of type III at 1.5 M NaCI. identity. No peaks corresponding to Pi, or fia were observed on gel filtration. The amino acid composition and the carbohydrate content of the a-chains isolated from normal and fibrotic lungs are listed in Table II . The values obtained for normal and fibrotic collagens, both type I and type III, are identical within experimental error except possibly for the degree of lysine hydroxylation. The content of hydroxylysine was consistently observed to be lower in the al (I) and the al (III) chains isolated from the diseased lungs than that obtained from normal lungs (Table   II ). The composition obtained for the lung collagen chains in the present study is also in agreement with the composition reported previously for type I and type III collagens of human skin (14, 28) aorta (12, 13) and leiomyoma (12) , except that the lung collagens contain elevated amounts of hydroxlysine.
To further characterize the covalent structure of type III collagen of lung, the al (III) chain obtained by CMcellulose and agarose chromatography was cleaved at the methionyl residues by treatment with CNBr, and the resulting peptides were fractionated on CM-cellulose at pH 3.8 (Fig. 2) . Each of the peptides was further purified as outlined below. Peptides 1 and 2 were rechromatographed on phosphocellulose and molecular weights determined by Sephadex G-50 SF gel filtration. Sephadex G-50 SF likewise was used for isolation and molecular weight determination of peptides 3, 6, and 7. The larger peptides 4, 5, and 8 were further purified by rechromatography on CM-cellulose at pH 4.8 (24) . Their molecular weights were determined on agarose A 1.5m (25) . Peptide 9 could only partially be eluted by the gradient used. Application of 1 M NaCi solution, however, removed the bulk of the peptide. On agarose A 1.5m gel filtration, peptide 9 eluted as two peaks; one with a mol wt of 23,000 and the other with a mol wt of 45,000. Both, however, had an identical amino acid composition. Since the peptide contains a residue of cysteine, presumably the larger peptide represents a dimer of the peptide linked together through a disulfide bridge. A similar polymerization of the peptide was noted by Chung et al. (29) in the CNBr peptides from uterine leiomyoma. The amino acid composition and molecular weight of the purified CNBr peptides are presented in Table III . The sum of the composition of the peptides agree within experimental error, with the observed composition of al (III). The data are also in agreement with the values obtained on the CNBr peptides of uterine leiomyoma (29) .
The lung al (I) and a2 chains were also further characterized by cyanogen bromide digestion, and separation of the resulting peptides by CM-cellulose chromatography and agarose A 1.5m gel filtration. The elution patterns from CM-cellulose chromatography are shown for comparison in Fig. 2 . Each of the peptides was further purified by the procedures described for the al (III) peptides. No differences were noted from the results obtained from analyses of human skin al (I) and a2 with respect to molecular weights and amino acid composition (data not shown) (30) .
Next, the question of collagen polymorphism in normal and fibrotic lungs was investigated. Because of the fact that pepsin solubilization yielded relatively small portions of the total collagen present in the lung, determination of the al (I): al (III) ratio in the extracted collagen would not have reflected their distribution in the tissue.
Thus, the washed total lung homogenates were subjected to CNBr digestion directly. Prior extraction of the homogenates with 0.05 M Tris, pH 7.4, and distilled water was essential to remove large quantities of noncollagenous proteins and other substances. Under the experimental conditions used in the present study, 88% or more of the total hydroxyproline was solubilized by CNBr digestion. CNBr digests were then fractionated on CM-cellulose. As shown in Fig. 3 For quantitative purposes, however, peptide 8 of type III collagen coeluted with al(I)-CB8 and al(I)-CB(8-3), and because of the difference in their molecular weight, these peptides could be separated by agarose A 1.5m chromatography (Fig. 4) . Three peaks were consistently seen. The first eluted at a position corresponding to a mol wt of 37,000 and was identified as uncleaved al (I)-CB (8-3) (22) . This was generally present as the shoulder on the next major peak identified as al (I)-CB8 with a mol wt of 24,000. The uncleaved al(I)-CB(8-3) usually represented 10-15% of the total al(I)-CB8 and was added to it to obtain quantitation of type I collagen. The last peak eluting at a position corresponding to a mol wt of 12,000 was identified as peptide 8 of type III collagen by amino acid analysis.
The molar ratio of type I and type III collagens present in lung was then calculated from the moler ratio of al(I)-CB8 plus a1(I)-CB(8-3) and peptide 8 of type III. Quantitation was based on the hydroxyproline assay of each of the peaks. Table IV summarizes the relative abundance of each collagen type in three normal and five fibrotic lungs. Significantly lower levels of type III collagen were consistently observed in the diseased lung.
To assess the reliability and the reproductibility of these determinations under our conditions, several experiment were performed: (a) Known amounts of purified al(I) and al(III) (CM-cellulose and agarose chromatography) were mixed to yield standard mixtures containing 10, 20, 30, and 40% al (III), and each mixture was separately digested with CNBr, and the resulting peptides were separated by CM-cellulose chromatography. A pattern obtained from a mixture consisting of 30% type III and 70% type I is shown in Fig. 3 . The material indicated by the horizontal bar was collected and after desalting and lyophilization, subjected to gel filtration on agarose A 1.5m (Fig. 4) . The percent of type III calculated from hydroxyproline analyses of the resulting peptide fractions was 28%. By identical maneuvers, values of 37, 22, and 9% al (III) were obtained from the mixtures containing 40, 20, and 10% type III, respectively. (c) Triplicate lung samples were taken from each of the following: one normal and two different patients. Each sample was separately digested with CNBr. The resulting peptides were separated by CM-cellulose and agarose chromatography in a manner described above. The percent of type III present in the triplicate samples agreed within 3 percentage points as indicated in Table IV .
DISCUSSION
Histopathologic studies indicate that the collagen content of human lung increases in chronic pulmonary fibrosis (17) . The chemical nature of collagen in lung has never been fully investigated and represents the aim of this investigation. Type I and type III collagens which are present in peripheral lung were made soluble by limited pepsin digestion under conditions which maintain the helical conformation of the molecule. Pepsin, under these conditions, cleaves only the nonhelical terminal segments which contain the lysine-derived interchain cross-links (31, 32) . The bulk of the collagen molecule is resistant to pepsin digestion so long as the native triple helix remains intact. Pepsin treatment of the total tissue, therefore, has been used to solubilize collagen with similar physical-chemical properties as the intact tropocollagen molecule.
The preservation of the triple helical structure enables extracted lung collagens to be purified by low salt precipitation (0.01 M Na2HPO), acid precipitation (0.5 M acetic acid with 1 M NaCI), and finally selective precipitation of types III and I collagens at 1.5 and 2.5 M NaCl (0.05 M Tris, pH 7.4), respectively. CM-cellulose chromatography of both the 1.5 and 2.5 M NaCl precipitates indicates that quantitative separation of the two types of collagen was not achieved, with a considerable amount of type III remaining in the 1. The possibility must also be considered that al (I) may be contaminated with al (II) from the remaining small bronchial tree or al (IV) from the remaining vasculature. Both of these might have been solubilized by pepsin digestion and eluted from CM-cellulose in a position similar to al (I) (15, 33) . The relatively high levels of hydroxylysine observed in this study might also be consistent with this supposition. The presence of significant amounts of type II collagen may, however, be ruled out from the following considerations. Human al (II) contains 14 residues/i,000 of hydroxylysine (34) . This would necessitate a large amount of contamination to account for the high level of the amino acid found in human lung al (I). At that level of contamination, the al (II) specific CNBr peptides would have been detected during isolation of the al (I) peptides. No such peptides were detected in the CNBr digests of lung al (I) .
Type IV collagen has not been characterized as well as the other types. However, available data indicate that it is distinguished by its high content of 3-hydroxyproline and carbohydrate (15, 16) . The lung al (I) in the present paper contained only about one residue each of 3-hydroxyproline and hydroxylysineglycosides, and thus a significant contamination by al (IV) is unlikely.
The amino acid composition of the lung a-chains revealed no significant differences between the normal and fibrotic lung collagen except for a possible decrease in lysine hydroxylations (Table II) in the diseased organ.
The observed values for hydroxylysine are 7.1 and 8.3 for al (I) and al (III) of the pathologic organ as compared with 10.0 and 11.1 for al(I) and al(III) of normal organ, respectively. These values should be interpreted with some caution, since slight variations were also observed in the total lysine content (lysine plus hydroxylysine) of various chains. The magnitude of the decrease in hydroxylysine, however, appears to be greater than accountable by variations in the measurement.
Proline hydroxylation was not altered in the diseased organ. This is interesting in view of the fact that the posttranslational enzymes, i.e., prolyl and lysyl hydroxylases have been shown to increase during experimentally induced fibrosis (35) . The fact that there is no increase in hydroxyproline or hydroxylysine content suggests that these increased enzymatic activities reflect an overall increased collagen synthesis incident to the fibrotic process. The levels of hydroxylysine in both normal and fibrotic lungs are higher when compared to human skin where the hydroxylysine content has been reported to be 5 or 6/1,000 residues (14, 29) . This must, therefore, represent a tissue-specific increase in lysine hydroxylation. The functional significance of this amino acid in collagen is not understood at the present time. The occurrence of tissue-specific differences in the content of hydroxylysine, and its alterations in certain diseased states, such as rickets (36), however, do suggest its involvement in some aspect of collagen function.
Glycosylation of both fibrotic and normal lung collagen, types I and III, was found to be identical. al(I) contained approximately 0.8 residue of 0-glucosylgalactosylhydroxylysine and 0.3 residue of 0-galactosylhydroxylysine per chain. Type III collagen contained approximately the same amount. No correction factors were used to account for partial destruction due to hydrolysis. The lack of change in the degree of glycosylation of hydroxylysine in chronic pulmonary fibrosis is at variance with the data obtained from scarred rabbit cornea in which substantial decreases in glycosylation were noted in the scar tissue as compared to the control (37) . That data, however, was obtained from collagenase digests of total tissue, rather than from purified collagen, and must therefore be regarded with a certain degree of uncertainty.
The CNBr peptides from lung al(I), a2, and al(III) were isolated and characterized with respect to molecular weight and amino acid composition. Nine peptides were obtained from CNBr digestion of type III human lung collagen, and were purified by a combination of ion exchange and molecular sieve chromatography. The amino acid compositions were in agreement with those obtained from human skin (29) , with the exception of peptides 1, 3, and 6. In the present study no leucine or isoleucine was found in peptide 1, while one each of the amino acids was previously found (29) . Whether these differences represent tissue-specific variations is not known. Peptide 3 contained 91 amino acids as opposed to 109 which was previously reported for skin (29) . Although the sequence of these CNBr peptides within the a-chain has not been established, peptide 3 most likely represents the amino terminus since two tyrosine residues are present. In type I collagen, tyrosine is present only in the amino or carboxy terminal peptide. Variable pepsin digestion would have therefore yielded discrepancies in the length of this peptide and explain the difference. The partial amino acid sequence of peptides 4, 5, and 6 has already established their analogy with CB3, CB7, and CB8 of al (I) polypeptide chain (38) . Peptide 9 contained the two cysteine residues.
It was isolated as a monomer and dimer with mol wt of 23,000 and 45,000, respectively, with the same amino acid composition. This peptide was reported to be the carboxy terminal peptide, and therefore analogous to al (I)-CB6. The position of peptides 1, 2, 7, and 8 in relation to al (I) chain has not yet been determined. No significant differences were observed in the CNBr Collagen Polymorphism in Idiopathic Chronic Pulmonary Fibrosis peptides of human lung al (I) and a2 as compared to those of corresponding human skin chains (30) .
The specific nature of the CNBr cleavage and the resulting peptides allowed investigation of collagen polymorphism in normal and diseased lung. Peptide 8 of type III collagen coeluted from CM-cellulose with al (I) -CB8 and the partially cleavaged CB . Since the latter peptides are larger in mol wt (24,000 and 37,000, respectively) as opposed to peptide 8 of al(III), they were readily separated by agarose A 1.5m chromatography. Because of the reproducible elution pattern in this area of the CM-cellulose chromatogram, no difficulties were encountered in identifying and pooling consistant fractions, even in CNBr digests of the total tissue. Since quantitation was based on hydroxyproline assay, possible contamination by noncollagenous proteins would not have produced errors. In reality, however, quantitation by planimetry of the area under the chromatographic peaks yielded nearly identical results. The reproducibility of the procedures used in this study was supported by experiments using artificial mixtures of purified type I and type III collagens as well as by good agreement obtained in triplicate analyses of several lung samples (Table IV) .
Normal lung contained an average of 31% type III collagen. Variable results were obtained from fibrotic lungs, depending on the patient, with a range of 12-24% type III collagen. This is presumably related to the varying severity among different patients, but no attempt was made to quantitatively correlate the biochemical findings with histopathologic findings. The consistant depression in type III collagen indicates that the fibrotic response of this tissue to injury, whatever it may be in chronic pulmonary fibrosis, is to result in a relative increase in the amount of type I in relation to type III collagen. Whether this is due to a preferential increase in the synthesis of type I collagen or due to a preferential increase in the degradation of type III collagen, or both, cannot be decided at present.
An additional possibility must also be considered that the relative diminution in the content of type III may be a result of a reduction in the relative amount of blood vessels in the diseased lung and not due to any changes in the collagen composition of lung scar per se. It was previously reported that blood vessels are relatively rich in type III collagen (13) . To our knowledge, there have been no studies designed to quantitate the blood vessel content of lung in normal or diseased states. Microscopic examination of pathologic lung slides might suggest that the blood vessel content may be diminished. Our preliminary results obtained from studies of scleroderma lungs from one patient, however, suggest that such a possibility is less likely, at least as an entire explana-tion of the observed collagen distribution. Although the scleroderma lungs showed much of the same pathologic features as the idiopathic fibrosis, the relative distribution of type I and III collagens was unaltered.
Thus, it is not yet possible to precisely relate the biochemical findings to specific anatomic or pathologic loci in lung. Nevertheless, the results obtained in the present investigation do define biochemical changes in collagen in this disorder and provide basis for further investigation.
